Summary This report describes a population-based case-control study that 
(OR=27.1, 95% Cl 6.0-122). Most other birth defect groups were also associated with increased cancer risk. The increased risk of leukaemia in children with Down's syndrome was confirmed, and children with central nervous system (CNS) defects were found to be at increased risk of CNS tumours. The report confirms that children with congenital malformations have increased risks of various malignancies. These findings may provide clues to the underlying aetiology of childhood cancer, as congenital malformations are felt to be a marker of exposures or processes which may increase cancer risk. The usefulness of record linkage between accurate population-based registers in the epidemiological study of disease has also been reinforced.
Keywords: congenital matformations; childhood cancer: case-control study: record linkage Associations have been reported between congenital malformations and cancer in childhood. and it is considered that these conditions may be at the end of a common aetiological. in particular genetic. pathway. Through the study of such associations. the determination of underlying genetic changes involved in cancer may be possible (Narod et al. 1997 ). In addition. such knowledge of cancer risk in children with congenital malformations may lead to strategies for early detection of malignancy.
Victoria has three well-established. population-based registers collecting information on cancer. perinatal factors and birth defects in children. and covers a defined population with approximately 64 000 births annually. This unusual situation provided an opportunity to link the registers and assess any association between congenital malformations and childhood cancer.
PATIENTS AND METHODS Data sources
The Victorian Cancer Recister (VCR) Obstetric and Paediatric Mortality and Morbiditv. 1996) . representingy 99.6% of all births (Rilev and Griffin. 1997 Several other aspects of the study deserve notice. namely a potential bias in ascertainment of malformation information. control population selection. the malformation prevalence in the control children and the loss of cases in the record linkage process.
Because notification of malformations is voluntary. ascertainment may be incomplete for both cases and controls. Such nondifferential errors in exposure ascertainment would not greatly alter the odds ratios or. if they did. they ma) result in a bias towards lack of association (Wacholder et al. 1992) . It is possible that the relative ill-health of children with cancer promotes recognition and notification of malformations. To assess potential bias in malformation data ascertainment. the cancer diagnosis date was compared with the malformation notification date. For eight (14.5%c) of the 55 cases. the notification may not have occurred before. and may consequently not be independent of. the cancer diagnosis (although three of these children had perinatal neoplasms). When these cases are removed. the estimate of malformation prevalence in children with cancer remains high at 8.4%7. As the majority of children with cancer and malformations had their malformation notified well in advance of their cancer diagnosis. it is assumed that biased malformation data ascertainment did not play a major role in this study.
One problem with the control population was that it was only known whether they had survived to 29 days and not to the equivalent age of diagnosis of cancer in the corresponding case. While it is acknowledged that there mav be differential mortalitv (from causes other than cancer) in children w-ith congenital malformations compared with those without. death in childhood is a rare occurrence and any potential bias would be small. In addition. we believe that our existing, process involving multiple sources of notification of congenital malformations would ensure reporting of a potentially lethal malformation within the first 28 days of life.
The control children's birth defect prevalence rate (2.5%) is considered to be an accurate estimation of the prevalence of major malformations in the general population (Eurocat Working Group. 1995) . The higher prevalence in certain previous reports may be due to our exclusion of stillbirths and neonatal deaths from the control population. and also to possible differences in true prevalence. ascertainment and birth defect definitions.
As record linkage was not based on a unique identifier. the loss of 9.8% of the cancer cases is not considered to be excessive. and the comparison of linked and unlinked cases revealed no significant differences. Because linkage assumed that child and mother held the same sumame. failure to link records may have been due to surname differences. a name change since birth. or. more probably. the case child being born outside Victoria.
We found a fourfold risk of cancer in children with malformations. The overall malformation prevalence of 9.6%-is greater than the 7.7% and the 5.5% reported in two US register-based studies (Mili et al. 1993a and b) . and the 4.9%7 reported in children on a British cancer register (Narod et al. 1997) . However, it appears comparable to a case-control study in the UK that reported a malformation prevalence of 10.8% (Mann et al. 1993) . although this study included many trivial defects. which have been excluded from our study. These differences could be due to the previously discussed bias in malformation ascertainment, but probably reflect higher ascertainment of congenital malformations by the Victorian register.
The study confirmed the high risk of children with Down's syndrome developing cancer. The 64-fold risk of leukaemia in children with Down's syndrome is higher than previously reported in a review on the subject (Fong. 1987 ) and in Swedish registrybased study (Zack et al. 1991 ) . This may be due to differing ascertainment methodologies in the early studies on which the review is based. or that the Swedish study relied on congenital malformation reporting solely from the birth form. Some recognized cancer-congential malformation associations have been quantified. namely Down's syndrome and leukaemia. retinoblastoma and chromosomal defects. and Wilm's tumour and chromosomal defects. New associations include those found between central nervous system tumours and nervous system defects and eye/face/neck defects. and those between neuroblastoma and the same malformation groups.
These associations have a basic anatomical similarity. and this may point towards common embryological influences. There is also evidence that germline genetic defects lead to malformations. and either directly lead to the cancer or cause a predisposition to cancer development. Such defects have been found in subgroups of both Wilm's tumours (Riccardi et al. 1978 : Haber. 1992 : Coppes et al. 1993 ) and retinoblastomas (Knudson. 1971 : Cowell. 1994 . and more recently with Cowden disease and a aermline mutation in the tumour suppressor gene PTEN (Marsh et al. 1998 ).
The high. and statistically significant. odds ratios found in this study provide strong evidence of links between the presence of congenital malformations and the development of cancer in childhood. Many 'cancer-prone' congenital malformation syndromes have been described. for example. those associated with immune disorders. overgrowth syndromes. multiple hamartomas and chromosomal abnormalities (POSSUM. 1995) . Such congerntal malformations may be markers of other exposures or processes that increase the risk of childhood cancer. The identification of cancer-prone syndromes. confir'med with epidemiological evidence, should spur increased efforts to understand the underlying links. which may lead to the localization and function of gene mutations involved in cancer development (Narod et al. 1997 ).
Apart from adding to the small pool of knowledtge on childhood cancer aetiolog>y. our findingrs have emphasized the usefulness of accurate population-based registers in the elucidation of disease risk factors.
